Future of GPR109A agonists in the treatment of dyslipidaemia.
about
Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel DiseaseConsensus statement on management of dyslipidemia in Indian subjects.The atypical N-glycosylation motif, Asn-Cys-Cys, in human GPR109A is required for normal cell surface expression and intracellular signalingEffects of pyrazole partial agonists on HCA(2) -mediated flushing and VLDL-triglyceride levels in mice.Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes.Constitutive expression of HCA(2) in human retina and primary human retinal pigment epithelial cells.Measuring niacin-associated skin toxicity (NASTy) stigmata along with symptoms to aid development of niacin mimetics.
P2860
Q26741117-C34372B9-5EF0-4714-9B41-73C35C4A7CDEQ34980772-1D329E93-2CA6-4621-9059-58B91E8DD6B9Q35660100-36E4C8DA-F637-4A77-9A72-DE1E407D058BQ36619771-99B5422A-D13E-44B2-BD9C-259FF2F07F90Q36913813-FFAB92F5-6623-430F-B9C6-AB5E27CA1C6AQ39064720-3ECD67E1-F396-4DBD-8AEC-32FCE2B4B8D3Q40365888-33229597-6D08-42BE-ADB7-5365C68240E9
P2860
Future of GPR109A agonists in the treatment of dyslipidaemia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Future of GPR109A agonists in the treatment of dyslipidaemia.
@ast
Future of GPR109A agonists in the treatment of dyslipidaemia.
@en
Future of GPR109A agonists in the treatment of dyslipidaemia.
@nl
type
label
Future of GPR109A agonists in the treatment of dyslipidaemia.
@ast
Future of GPR109A agonists in the treatment of dyslipidaemia.
@en
Future of GPR109A agonists in the treatment of dyslipidaemia.
@nl
prefLabel
Future of GPR109A agonists in the treatment of dyslipidaemia.
@ast
Future of GPR109A agonists in the treatment of dyslipidaemia.
@en
Future of GPR109A agonists in the treatment of dyslipidaemia.
@nl
P2860
P1476
Future of GPR109A agonists in the treatment of dyslipidaemia.
@en
P2093
P2860
P304
P356
10.1111/J.1463-1326.2011.01400.X
P577
2011-08-01T00:00:00Z